Suction Catheters Market: as Avanos Medical’s March 2025 recall of certain Ballard Closed Suction Systems for a sterilization process failure demonstrates, even the closed suction category’s core clinical advantage, maintaining a sealed airway circuit to reduce ventilator-associated pneumonia risk, depends entirely on manufacturing sterility assurance holding up in practice, so hospital respiratory therapy purchasing increasingly weighs a manufacturer’s demonstrated quality system track record alongside the closed-versus-open design distinction itself.

The global suction catheters market size was USD 692.6 Million in 2025 and is expected to register a revenue CAGR of 5.4% during the forecast period. Market revenue growth is driven by factors such as rising mechanical ventilation dependency across ICU and critical care settings sustaining structural demand for both closed and open suction catheters, growing chronic respiratory disease burden expanding the population of patients requiring routine airway secretion management, and continued clinical preference for closed suction systems given their ventilator-associated pneumonia risk reduction relative to open suction technique. The first driving factor is rising mechanical ventilation dependency across ICU and critical care settings, sustaining structural demand for suction catheters that every mechanically ventilated patient requires for airway secretion management. Every mechanically ventilated patient requires regular airway suctioning to clear secretions and maintain airway patency, and rising ICU and critical care mechanical ventilation volume directly sustains suction catheter demand across both closed and open product categories. The second driving factor is growing chronic respiratory disease burden, expanding the population of patients requiring routine airway secretion management both in acute care and home care settings. Rising global prevalence of chronic obstructive pulmonary disease and other chronic respiratory conditions continues to expand the population of patients requiring routine suctioning support, extending suction catheter demand beyond the ICU into home care and long-term care settings. The third driving factor is continued clinical preference for closed suction systems, given their demonstrated ventilator-associated pneumonia risk reduction relative to open suction technique through maintaining a sealed airway circuit during suctioning. These are some of the key factors driving revenue growth of the market.

A second layer of demand comes from the way a single manufacturer’s quality system failure in the closed suction category can shift hospital purchasing sentiment and scrutiny across the broader category, letting one verified sterility or manufacturing event compound into heightened due diligence and, in some cases, purchasing hesitancy that extends beyond the specific manufacturer and product lot directly affected. Once a closed suction system manufacturer experiences a verified sterility or manufacturing quality failure, hospital respiratory therapy and infection prevention teams reasonably extend heightened scrutiny to the broader closed suction category during subsequent purchasing decisions, even for manufacturers not directly involved in the specific failure, so a single verified quality event and broader category purchasing scrutiny are directly linked in the period immediately following such an event. As a result, demand and purchasing preference are concentrating around manufacturers with the strongest demonstrated quality system track record and transparent recall response, and the forecast tilts toward manufacturers capable of maintaining sterility assurance credibility rather than the category commoditising purely on closed-versus-open design distinction alone. For instance, on March 19, 2025, Avanos Medical sent an Urgent Medical Device Recall Notice to customers regarding certain lots of Ballard Closed Suction Systems due to a failure in the sterilization process, an event the FDA identified as its most serious recall classification, illustrating how a single verified sterility failure at one manufacturer can directly affect purchasing confidence and due diligence practices across the broader closed suction category. These are some of the key factors driving revenue growth of the market.

The clearest driver of demand is the direct, mechanical relationship between mechanical ventilation utilisation and suction catheter consumption, since every mechanically ventilated patient requires regular airway suctioning to clear secretions and maintain airway patency. A mechanically ventilated patient cannot safely maintain airway patency without regular suctioning to clear accumulated secretions, and this clinical necessity applies to essentially every mechanically ventilated ICU and critical care patient regardless of the underlying reason for ventilation, so ICU and critical care mechanical ventilation volume and suction catheter demand are directly and mechanically linked. Rising ICU and critical care mechanical ventilation utilisation globally continues to sustain structural demand for the suction catheters every mechanically ventilated patient requires for routine airway secretion management. The effect on the market is that suction catheter unit demand growth tracks underlying mechanical ventilation utilisation relatively closely across both closed and open product categories. These are some of the key factors driving revenue growth of the market.

The second driver is the way a single manufacturer’s verified quality system failure in the closed suction category extends heightened scrutiny across the broader category, affecting purchasing confidence beyond the specific manufacturer directly involved. Closed suction systems command a clinical and price premium specifically because they maintain a sealed airway circuit that reduces ventilator-associated pneumonia risk, and this premium depends entirely on hospital confidence that the manufacturing sterility assurance behind that sealed system genuinely holds, so a verified sterility failure directly undermines the core value proposition the closed suction category depends on, extending scrutiny beyond the specific manufacturer involved. On March 19, 2025, Avanos Medical sent an Urgent Medical Device Recall Notice to affected customers regarding certain lots of Ballard Closed Suction Systems due to a failure in the sterilization process, a recall the FDA identified as its most serious classification given the risk of serious injury or death. The recent record shows the pace. The recall specifically addressed updating instructions for use rather than physically removing affected devices from distribution, reflecting the specific nature of the sterilization process failure identified. The effect on the market is that hospital respiratory therapy and infection prevention teams now weigh a manufacturer’s demonstrated quality system track record more heavily alongside the closed-versus-open design distinction itself when evaluating suction catheter purchasing decisions. These are some of the key factors driving revenue growth of the market.

“On March 19, 2025, Avanos Medical sent an Urgent Medical Device Recall Notice regarding certain lots of Ballard Closed Suction Systems due to a sterilization process failure, an FDA Class I recall reflecting the most serious classification, directly illustrating how the closed suction category’s core value proposition depends entirely on manufacturing sterility assurance holding up in practice.”

The third driver is the sustained global growth in chronic respiratory disease prevalence, extending suction catheter demand beyond the ICU into home care and long-term care settings where routine airway secretion management support is required. Patients with chronic obstructive pulmonary disease and other chronic respiratory conditions often require ongoing airway secretion management support outside the acute care hospital setting, and this clinical need is what extends suction catheter demand into home care and long-term care applications beyond the traditional ICU and critical care demand base. Rising global prevalence of chronic obstructive pulmonary disease and other chronic respiratory conditions continues to expand the population of patients requiring routine suctioning support across both acute care and home/long-term care settings. The effect on the market is that suction catheter demand growth increasingly extends beyond the traditional ICU and critical care base into home care and long-term care application settings. These are some of the key factors driving revenue growth of the market.

However, the suction catheters market faces adoption constraints from infection risk associated with ventilator-associated pneumonia that closed suction systems reduce but cannot eliminate entirely, pricing commoditisation in the open catheter segment constraining manufacturer pricing power, and sterility assurance and manufacturing quality risk that can affect purchasing sentiment following a verified event regardless of underlying product design. Because closed suction systems reduce, but do not entirely eliminate, ventilator-associated pneumonia risk, hospital infection prevention protocols continue to require comprehensive ventilator bundle compliance, including oral care protocols and head-of-bed elevation, beyond suction catheter selection alone, meaning suction catheter technology choice represents only one component of a broader infection prevention strategy that hospitals must implement comprehensively to realise the full risk reduction closed suction technology is capable of supporting. Pricing commoditisation in the open catheter segment compounds this, since open suction catheters have substantially standardised across compliant suppliers meeting recognised sterility and performance requirements, and low-cost manufacturer competition constrains pricing power in this segment even as the closed suction segment commands a genuine premium for its clinical differentiation, so overall category pricing power depends heavily on maintaining the closed segment’s premium positioning specifically. Sterility assurance and manufacturing quality risk is the third constraint, since, as demonstrated by the Avanos Medical Ballard recall in March 2025, sterility assurance failures can occur even at established, experienced manufacturers, and this residual manufacturing quality risk represents an ongoing consideration for hospital purchasing decisions that persists regardless of which specific product design category a hospital ultimately selects. These factors substantially limit suction catheters market growth over the forecast period.

Based on product type, the global suction catheters market is segmented into closed and open suction catheters. Closed suction catheters hold the largest revenue share, because they command a premium price reflecting their ventilator-associated pneumonia risk reduction benefit relative to open suction technique, which suits leading manufacturers including Avanos Medical and Vyaire Medical’s established closed system product lines. Open suction catheters are expected to register a significantly large revenue share in the global suction catheters market over the forecast period, reflecting their continued use in settings and procedures where the closed system’s specific infection prevention benefit is less clinically material.

PVC material is expected to account for the largest revenue share in the global suction catheters market during the forecast period

Based on material, the global suction catheters market is segmented into PVC and silicone materials. PVC material holds the largest revenue share, reflecting its established position as the standard suction catheter material given its cost efficiency and adequate performance for the majority of suctioning applications. Silicone material is expected to register rapid revenue growth in the global suction catheters market over the forecast period, driven by its lower tissue trauma risk during extended or repeated use, which is why this material represents a growing area of product development for chronic and long-term care applications specifically.

Mechanical ventilation/ICU application is expected to account for the largest revenue share in the global suction catheters market during the forecast period

Based on application, the global suction catheters market is segmented into mechanical ventilation/ICU and chronic respiratory disease management applications. Mechanical ventilation/ICU holds the largest revenue share, reflecting the direct, mechanical link between ICU mechanical ventilation volume and suction catheter consumption in this highest-acuity application setting. Chronic respiratory disease management is expected to register rapid revenue growth in the global suction catheters market over the forecast period, driven by rising chronic obstructive pulmonary disease prevalence extending demand into home and long-term care settings, which is why this application represents a growing area of market expansion beyond the traditional ICU base.

Based on regional analysis, the suction catheters market in North America accounted for largest revenue share in 2025. The United States leads because it hosts the largest concentration of ICU and critical care mechanical ventilation capacity globally, and because Avanos Medical and Vyaire Medical both concentrate significant commercial and regulatory activity in the country. The FDA’s direct regulatory oversight of suction catheter quality, including its Class I recall classification applied to the March 2025 Ballard Closed Suction System recall, shapes United States hospital purchasing scrutiny and manufacturer quality system accountability specifically. The concentration of the largest ICU capacity base and leading suction catheter manufacturers in the United States also means new suction catheter technology and quality-related regulatory action are typically most visible in the United States first.

The market in Europe is expected to register a steady revenue growth rate over the forecast period. Germany, the United Kingdom, and France represent the three largest national suction catheters markets within Europe. The region’s established ICU infrastructure and CE-marking regulatory pathway under the Medical Device Regulation sustain steady demand. The result is steady rather than rapid growth, shaped more by the region’s already-mature ICU infrastructure than by unmet clinical demand.

The market in Asia Pacific is expected to register a rapid revenue growth rate over the forecast period. China, Japan, and India represent the three largest national suction catheters markets within the region. Expanding ICU capacity investment and rising chronic obstructive pulmonary disease prevalence in China and India are driving new demand from a comparatively lower installed base, leaving more room for growth than in the already-mature North America and Europe markets.

The market in Latin America is expected to register a moderate revenue growth rate over the forecast period. Brazil and Mexico represent the two largest national suction catheters markets within the region. Hospital ICU capacity in both countries continues gradually expanding, and the indirect effects of Iran-US sanctions and the associated Strait of Hormuz shipping disruption have kept freight and import costs elevated for the specialised PVC and silicone raw materials that Latin American suction catheter manufacturers and hospitals depend on through 2026, slowing adoption beyond the region’s main urban centres.

The market in Middle East and Africa is expected to register a moderate revenue growth rate over the forecast period. Saudi Arabia and the UAE represent the primary commercial suction catheters markets within the GCC. The UAE is the most established suction catheters market on the continent given its concentrated private hospital ICU infrastructure, while the wider Gulf states and broader African markets are still building the critical care capacity that suction catheter demand depends on.